New Insights into Diagnosis and Treatment of Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer
Main Authors: | Piotr L. Chlosta, Tomasz Golabek, Péter Nyirády |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2017/6467072 |
Similar Items
-
Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients
by: Mikolaj Przydacz, et al.
Published: (2021-05-01) -
Novel trends in transrectal ultrasound imaging of prostate gland carcinoma
by: Tomasz Szopiński, et al.
Published: (2014-09-01) -
Chromium in urothelial carcinoma of the bladder
by: Tomasz Golabek, et al.
Published: (2017-12-01) -
Obesity and renal cancer incidence and mortality – a systematic review of prospective cohort studies
by: Tomasz Golabek, et al.
Published: (2015-12-01) -
A Unique Urinary Metabolic Feature for the Determination of Bladder Cancer, Prostate Cancer, and Renal Cell Carcinoma
by: Sujin Lee, et al.
Published: (2021-09-01)